Skip to main content
Premium Trial:

Request an Annual Quote

Dutch Groups Team on Personalized Medicine Project

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Three Dutch institutes have joined forces in a public-private partnership to invest €28 million in personalized medicine projects, they announced today.

The three groups — the BioMedical Materials Program, the Center for Translational Molecular Medicine, and the Top Institute Pharma — have already selected seven projects that will receive funding from the collaboration. The projects will focus on personalized medicine research in cardiovascular diseases and cancer.

The projects being funded will focus on developing image-guided and targeted-delivery techniques, which the partners said are highly interdisciplinary and leverage the strengths of the three institutes. Top Institute Pharma is focused on drug development, while CTMM works on molecular diagnostics, and BMM specializes in biomaterials and regenerative medicine.

The seven projects selected by the partners brings together 12 knowledge institutes and 14 industrial parties and were the result of an earlier call for proposals.

"The outstanding quality of the proposals selected from the joint call should really help us to put personalized medicine into practice," Hans Hoogervorst, chairman of the supervisory board of CTMM said in a statement.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.